5-Amino-1MQ side effects liver questions have no human answers yet. Learn what animal data, NNMT biology, and bloodwork can and cannot tell you.
There is no published human data on 5-Amino-1MQ liver side effects. Because 5-Amino-1MQ is a research chemical and not FDA-approved for human use, no one can say whether it raises liver enzymes, causes liver injury, or is safe for people who already have liver disease. The sections below summarize what animal research shows, why the liver attracts so much attention with this compound, and which warning signs would justify a doctor visit.
What Is 5-Amino-1MQ?
5-Amino-1MQ, also written 5-amino-1-methylquinolinium, is a small-molecule inhibitor of nicotinamide N-methyltransferase, an enzyme known as NNMT. NNMT is abundant in the liver and in fat tissue, where it consumes SAMe, the body's primary methyl donor.
In obese mice, blocking NNMT has been associated with lower body fat, better glucose tolerance, and less fat buildup in the liver. That last finding is why the liver question keeps coming up: the organ that responds most to NNMT inhibition is also the organ that has to process the compound.
Why the Liver Is the Main Safety Question
The liver has the highest NNMT activity of any human tissue. Inhibiting that enzyme alters methylation chemistry inside liver cells, and methylation touches fat metabolism, gene regulation, and detoxification.
Three specific concerns come up repeatedly in research discussions:
- Methylation shifts. NNMT inhibition raises SAMe and lowers SAH in tissue, changing the ratio that governs hundreds of methylation reactions. Whether that shift is helpful or harmful in humans has never been tested.
- Unknown human metabolism. No public data describes how 5-Amino-1MQ is broken down or cleared in people, so how long it lingers in the liver is unknown.
- Stacking. Users frequently combine it with other research compounds, and no study has examined how those combinations affect liver tissue.
It is worth noting that the mouse evidence points the other way. Rodent studies have generally shown reduced liver fat after NNMT inhibition, not toxicity.
Animal results do not automatically carry over to humans, and a compound that has never completed a Phase I trial has no established liver safety profile.
Side Effects Reported by Users
Without clinical trials, all side-effect information comes from forums and personal logs rather than monitored studies. That makes it context, not evidence.
- Injection site redness or soreness with subcutaneous use
- Fatigue, jitteriness, or disrupted sleep
- Headaches and lightheadedness
- Appetite suppression
- Vivid or unusual dreams
No published case report has documented liver injury from 5-Amino-1MQ. A lack of case reports is not proof of safety, since most users never get bloodwork drawn.
The broader list of 5-amino-1mq side effects that users discuss rarely mentions the liver at all, which is exactly why the liver question remains open. Anyone who has read through bpc 157 side effects liver reports will recognize the pattern: anecdotal reassurance with no lab data behind it.
How 5-Amino-1MQ Compares With Other Research Compounds
Liver-related risk signals vary across research compounds, and most of them share the same core limitation: no human safety trials.
| Compound | Primary research use | Human liver safety data | Reported liver-related signals |
|---|---|---|---|
| 5-Amino-1MQ | NNMT inhibition; metabolic research | None — no clinical trials | Reduced liver fat in mice; no human data |
| BPC-157 | Tissue repair and gut research | None for human use | No consistent injury signal in animal studies |
| AOD-9604 | Fat metabolism research | Limited early human studies | No clear liver signal reported |
| CJC-1295 | Growth hormone research | None | No human liver data |
| DSIP | Sleep research | None | No human liver data |
Because the comparison is mostly a list of unknowns, summaries of aod-9604 benefits and side effects and discussions of cjc 1295 long-term side effects tend to reach the same conclusion: the data simply is not there. The same holds for dsip side effects, where nearly everything published comes from animal models.
Warning Signs of Liver Problems
Anyone using an unapproved compound should know the symptoms that warrant prompt medical attention:
- Yellowing of the skin or the whites of the eyes
- Dark urine or pale, clay-colored stools
- Pain or tenderness in the upper right abdomen
- Persistent nausea, vomiting, or loss of appetite
- Unusual fatigue, confusion, or easy bruising
These symptoms are not specific to 5-Amino-1MQ and can have many causes. They still justify stopping the compound and seeing a physician promptly.
Bloodwork and Risk Reduction
5-Amino-1MQ is not approved for human use in the United States, and it is sold as a research chemical that is not intended for human consumption. That label is not a technicality — it means the product has not been evaluated for purity, dosing, or safety in people.
If someone is considering it anyway, a baseline liver panel is the minimum sensible step. Ask a healthcare provider for:
- ALT and AST (liver enzymes)
- Alkaline phosphatase and GGT
- Total and direct bilirubin
- Albumin and total protein
Repeat testing after a few weeks gives a far better picture than guessing from how you feel, because early liver stress is often silent.
Anyone with existing fatty liver disease, hepatitis, alcohol use disorder, or a history of elevated liver enzymes has extra reason for caution. So does anyone taking prescription medication that the liver processes, including acetaminophen at high doses, statins, or certain antibiotics.
The Bottom Line
5-Amino-1MQ has no human liver safety data, no approved dose, and no regulated supply chain. The optimism around it comes from rodent studies showing reduced liver fat, not from evidence that it is safe in people.
No one can currently state whether 5-Amino-1MQ raises liver enzymes in humans. If you use it or are considering it, get baseline and follow-up liver panels through a licensed healthcare professional, and stop immediately if symptoms of liver stress appear.
Frequently Asked Questions
Does 5-Amino-1MQ cause liver damage?
No published human study has shown that 5-Amino-1MQ damages the liver, but none has shown it is safe either. Animal research links NNMT inhibition to less liver fat rather than injury. Without clinical trials, the risk to human liver tissue remains unquantified.
What are the most common 5-Amino-1MQ side effects?
Self-reported effects include injection site irritation, headaches, fatigue, appetite suppression, and vivid dreams. These reports come from user forums rather than controlled trials, so their true frequency and cause are unknown.
Should I get bloodwork if I use 5-Amino-1MQ?
Yes. A baseline liver panel with ALT, AST, alkaline phosphatase, bilirubin, and GGT, repeated a few weeks later, is the most reliable way to detect early liver stress. Share the results with a healthcare provider before continuing.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.